MedTrace Logo

Monitoring of Donor-specific Antibodies After Treatment With Immunoglobulins, Plasmapheresis and Rituximab in Lung Transplantation

NCT03798860 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 340

Last updated 2026-03-25

No results posted yet for this study

Summary

Single-arm, prospective observational study

Conditions

  • Lung Transplantation
  • Donor-specific Anti-human Leukocyte Antigen(HLA) Antibodies

Interventions

DIAGNOSTIC_TEST

blood samples

For performing the Luminex solid phase assay (SPA) test, 7.5 ml of patient whole blood are collected from a peripheral vein.

Sponsors & Collaborators

  • Hannover Medical School

    lead OTHER

Principal Investigators

  • Fabio Ius, Dr. · Hannover Medical School

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03798860 on ClinicalTrials.gov